Elizabeth A. GallenaghTraceability/SerializationOp-ed: Collaboration Is Critical for DSCSA StabilizationThe FDA recently announced a DSCSA “stabilization policy,” but further clarity and education will be needed for all trading partners to ensure they reach compliance.October 26, 2023Traceability/SerializationOp-ed: Phased Approach to DSCSA an Alternative to Nov. 27 DisruptionsThe pharmaceutical supply chain is not where it needs to be as the DSCSA deadline approaches. A new approach is necessary to ensure the safe and secure delivery of medicines come November.July 6, 2023Traceability/SerializationOp-ed: Data Issues Abound as DSCSA Deadline NearsTrading partners are working diligently to connect data systems in compliance with the Drug Supply Chain Security Act (DSCSA). But significant challenges remain ahead of the November finish line.February 22, 2023Page 1 of 1Top StoriesSupply ChainFDA Launches PreCheck to Accelerate Domestic Drug Facility ApprovalsThe two-phase program is designed to expedite the approval of new pharmaceutical manufacturing facilities in the U.S. by providing enhanced regulatory guidance and communication to manufacturers.PharmaceuticalsPharmaceutical Packaging Innovations Report Video InterviewTraceability/SerializationThrough the Line Podcast: Improving DSCSA Data Exchange AccuracyPMMI News2025 Packaging State of the Industry: U.S. Expands, Canada MaintainsSupply ChainWhy Is Supply Chain Visibility and Transparency More Critical Now Than Ever Before?
